Flow cytometry: A clinical test of platelet function

Blood

Volumn 87, Issue 12, 1996, Pages 4925-4936

  Michelson, Alan D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; BETA THROMBOGLOBULIN; CALCIMYCIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; PADGEM PROTEIN; STREPTAVIDIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE ANTIGEN; THROMBOCYTE FACTOR 4; THROMBOXANE A2;

ACUTE HEART INFARCTION; ANGINA PECTORIS; BERNARD SOULIER DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 0029895895     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.4925.bloodjournal87124925     Document Type: Review

References (145)

1. Bizzozero G: Ueber einer neuen Formbestandtheil-Blutes und Desser Role bei der Thrombose und der Blutgerinnung. Arch Pathol Anat Physiol 90:261, 1881
2. Majerus PW: Platelets, in Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds): The Molecular Basis of Blood Diseases. Philadelphia, PA, W.B. Saunders, 1994, p 753
3. Plow EF, Ginsberg MH: Molecular basis of platelet function, in Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology. Basic Principles and Practice. New York, NY, Churchill Livingstone, 1995, p 1524
4. Rodgers RPC, Levin J: A critical reappraisal of the bleeding time. Semin Thromb Hemost 16:1, 1991
5. Kinlough-Rathbone RL, Packham MA, Mustard JF: Platelet aggregation, in Harker LA, Zimmerman TS (eds): Measurements of Platelet Function. New York, NY, Churchill Livingstone, 1983, p 64
6. George JN, Shattil SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 324:27, 1991
7. Kaplan KL, Owen J: Radioimmunoassays of platelet alpha-granule proteins, in Harker LA, Zimmerman TS (eds): Measurements of Platelet Function. Edinburgh, UK, Churchill Livingstone, 1983, p 115
8. Levine SP: Secreted platelet proteins as markers for pathological disorders, in Phillips DR, Shuman MA (eds): Biochemistry of Platelets. Orlando, FL, Academic, 1986, p 378
9. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN: Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 83:1535, 1994
10. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA: Platelet activation in unstable coronary disease. N Engl J Med 315:983, 1986
11. Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ: Clinical implications of prostaglandin and thromboxane A2 formation. N Engl J Med 319:689, 1988
12. Wu KK, Hoak JC: Increased platelet aggregates in patients with transient ischemic attacks. Stroke 6:521, 1975
13. Flores NA, Sheridan DJ: The pathophysiological role of platelets during myocardial ischaemia. Cardiovasc Res 28:295, 1994
14. Gasperetti CM, Gonias SL, Gimple LW, Powers ER: Platelet activation during coronary angioplasty in humans. Circulation 88:2728, 1993
15. Harker LA, Malpass TW, Branson HE, Hessel EA, Slichter SJ: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective α-granule release. Blood 56:824, 1980
16. Joseph R, Riddle JM, Welch KM, D'Andrea G: Platelet ultrastructure and secretion in acute ischemic stroke. Stroke 20:1316, 1989
17. Strano A, Davi G, Patrono C: In vivo platelet activation in diabetes mellitus. Semin Thromb Hemost 17:422, 1991
18. Hawkins RI: Smoking, platelets and thrombosis. Nature 236:450, 1972
19. Carvalho AC, Colman RW, Lees RS: Platelet function in hyperbetalipoproteinemia. N Engl J Med 290:434, 1974
20. Levine SP, Towell BL, Suarez AM, Knieriem LK, Harris MM, George JN: Platelet activation and secretion associated with emotional stress. Circulation 71:1129, 1985
21. Wang JS, Jen CJ, Kung HC, Lin LJ, Hsiue TR, Chen HI: Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation 90:2877, 1994
22. Rinder HM, Snyder EL: Activation of platelet concentrate during preparation and storage. Blood Cells 18:445, 1992
23. Shattil SJ, Cunningham M, Hoxie JA: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307, 1987
24. Givan AL: Flow Cytometry. First Principles, New York, NY, Wiley-Liss, 1992
25. Ejim OS, Powling MJ, Dandona P, Kernoff PB, Goodall AH: A flow cytometric analysis of fibronectin binding to platelets from patients with peripheral vascular disease. Thromb Res 58:519, 1990
26. Wehmeier A, Tschope D, Esser J, Menzel C, Nieuwenhuis HK, Schneider W: Circulating activated platelets in myeloproliferative disorders. Thromb Res 61:271, 1991
27. Michelson AD, Barnard MR, Benoit SE, Mitchell J, Knowles C, Ault KA: Characterization of platelet binding of blind panel mAb, in Schlossman SF, Boumsell L, Gilks W, Harlan JW, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF (eds): Leucocyte Typing V. Oxford, UK, Oxford, 1995, p 1207
28. Michelson AD, Shattil SJ: The use of flow cytometry to study platelet activation, in Watson SP, Authi K (eds): Platelet Function and Signal Transduction: A Practical Approach. Oxford, UK, Oxford, 1996, p 111
29. Shattil SJ, Hoxie JA, Cunningham M, Brass LF: Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 260:11107, 1985
30. Ginsberg MH, Frelinger AL, Lam SC, Forsyth J, McMillan R, Plow EF, Shattil SJ: Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood 76:2017, 1990
31. Frelinger AL, Lam SC, Plow EF, Smith MA, Loftus JC, Ginsberg MH: Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem 263:12397, 1988
32. Frelinger AL, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC, Ginsberg MH: Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem 265:6346, 1990
33. Zamarron C, Ginsberg MH, Plow EF: Monoclonal antibodies specific for a conformationally altered state of fibrinogen. Thromb Haemost 64:41, 1990
34. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ: Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 75:128, 1990
35. Gralnick HR, Williams SB, McKeown L, Shafer B, Connaghan GD, Hansmann K, Vail M, Magruder L: Endogenous platelet fibrinogen: Its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogen. Br J Haematol 80:347, 1992
36. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF: A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101:880, 1985
37. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B: PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305, 1989
38. Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, van Iwaarden F, Sixma JJ: Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70:838, 1987
39. Febbraio M, Silverstein RL: Identification and characterization of LAMP-1 as an activation dependent platelet surface glycoprotein. J Biol Chem 265:18531, 1990
40. Boukerche H, McGregor JL: Characterization of an antithrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Eur J Biochem 171:383, 1988
41. Aiken ML, Ginsberg MH, Plow EF: Mechanisms for expression of thrombospondin on the platelet cell surface. Semin Thromb Hemost 13:307, 1987
42. Hayward CP, Smith JW, Horsewood P, Warkentin TE, Kelton JG: p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem 266:7114, 1991
43. Hayward CP, Bainton DF, Smith JW, Horsewood P, Stead RH, Podor TJ, Warkentin TE, Kelton JG: Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest 91:2630, 1993
44. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205, 1988
45. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ: Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 266:17261, 1991
46. Phillips DR, Charo IF, Parise LV, Fitzgerald LA: The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831, 1988
47. Abrams C, Deng YJ, Steiner B, O'Toole T, Shattil SJ: Determinants of specificity of a baculovirus-expressed antibody Fab fragment that binds selectively to the activated form of integrin alpha lib beta 3. J Biol Chem 269:18781, 1994
48. Faraday N, Goldschmidt-Clermont P, Dise K, Bray PF: Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med 123:728, 1994
49. Heilmann E, Hynes LA, Burstein SA, George JN, Dale GL: Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets. Cytometry 17:287, 1994
50. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF: CD antigens 1993. Blood 83:879, 1994
51. Hsu-Lin S-C, Berman CL, Furie BC, August D, Furie B: A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 259:9121, 1984
52. Hamburger SA, McEver RP: GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 75:550, 1990
53. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359:848, 1992
54. McEver RP: Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 16:73, 1990
55. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Valeri CR: In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Blood 84:320a, 1994 (abstr, suppl 1)
56. Michelson AD, Wencel-Drake JD, Kestin AS, Barnard MR: Platelet activation results in a redistribution of glycoprotein IV (CD36). Arterioscler Thromb 14:1193, 1994
57. Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD: The effect of strenuous exercise on platelet activation state and reactivity. Circulation 88:1502, 1993
58. Ruggeri ZM: The platelet glycoprotein Ib-IX complex. Prog Hemost Thromb 10:35, 1991
59. Michelson AD: Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-IX complex. Semin Thromb Hemost 18:18, 1992
60. Michelson AD, Barnard MR: Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 70:1673, 1987
61. Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS: Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, ADP or an in vivo wound. Blood 77:770, 1991
62. Michelson AD, Benoit SE, Furman MI, Barnard MR, Nurden P, Nurden AT: The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: Proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system. Blood 87:1396, 1996
63. Hourdille P, Heilmann E, Combrie R, Winckler J, Clemetson KJ, Nurden AT: Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 76:1503, 1990
64. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J: Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 87:571, 1991
65. LaRosa CA, Rohrer MJ, Rodino LJ, Benoit SE, Barnard MR, Michelson AD: Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg 19:306, 1994
66. Abrams C, Shattil SJ: Immunological detection of activated platelets in clinical disorders. Thromb Haemost 65:467, 1991
67. Michelson AD: Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: Methods and clinical studies. Blood Coagul Fibrinolysis 5:121, 1994
68. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD: Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 72:957, 1994
69. Hansen SR, Harker LA: Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin PPACK. Proc Natl Acad Sci USA 85:3184, 1988
70. Eidt JF, Allison P, Nobel S, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT: Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 84:18, 1989
71. Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson SR, Harker LA: Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 77:1006, 1991
72. Vu TH, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057, 1991
73. Yamamoto N, Greco NJ, Barnard MR, Tanoue K, Yamazaki H, Jamieson GA, Michelson AD: Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood 77:1740, 1991
74. Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birjiniuk V, Ouimet H, Pasche B, Nelson MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD: The platelet function defect of cardiopulmonary bypass. Blood 82:107, 1993
75. Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF: Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 11:281, 1985
76. Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillman RS: Correlated measurement of platelet release and aggregation in whole blood. Cytometry 10:448, 1989
77. Michelson AD, Benoit SE, Kroll MH, Li J, Rohrer MJ, Kestin AS, Barnard MR: The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood 83:3562, 1994
78. Ruf A, Patscheke H: Flow cytometric detection of activated platelets: Comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost 21:146, 1995
79. Rinderknecht H: Ultra-rapid fluorescent labelling of proteins. Nature 193:167, 1962
80. Horsewood P, Hayward CP, Warkentin TE, Kelton JG: Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood 78:1019, 1991
81. Johnston GI, Pickett EB, McEver RP, George JN: Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood 69:1401, 1987
82. Poon RYM, Johnson R, Stanton T, Fernandez-Repollet E, Schwartz A: Calibration of fluorescent intensity microbead standards and assignment of effective fluorescein/protein ratios to the fluorescein isothiocyanate (FITC)-conjugated secondary antibodies used in the Fifth Workshop, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing V. Oxford, UK, Oxford, 1995, p 13
83. Nurden AT: Congenital abnormalities of platelet membrane glycoproteins, in Kunicki TJ, George JN (eds): Platelet Immunobiology. Philadelphia, PA, J.B. Lippincott, 1989, p 63
84. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 61:99, 1983
85. Montgomery RR, Kunicki TJ, Taves C, Pidard D, Corcoran M: Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest 71:385, 1983
86. Michelson AD, Barnard MR: Flow cytometric detection of the redistribution of the glycoprotein Ib-IX complex on thrombin-stimulated platelets is dependent on the type of antibody conjugate used. Response. Blood 81:1408, 1993
87. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242, 1992
88. Williams AE, Freeman MR, Chisholm RJ, Patt NL, Armstrong PW: Angiographic morphology in unstable angina pectoris. Am J Cardiol 62:1024, 1988
89. Sherman CT, Litvack F, Grundfest W, Lee M, Mickey A, Chaux A, Kass R, Blanche C, Matloff J, Morgenstern L: Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 315:913, 1986
90. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897, 1980
91. Antiplatelet Trialists' Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 296:320, 1988
92. Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC: Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 10:998, 1987
93. Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K: The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group. Coron Artery Dis 5:339, 1994
94. Schultheiss HP, Tschoepe D, Esser J, Schwippert B, Roesen P, Nieuwenhuis HK, Schmidt Soltau C, Strauer B: Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest 24:243, 1994
95. Furman MI, Benoit SE, Becker RC, Borbone M, Weiner BH, Michelson AD: Thrombin receptor-mediated platelet reactivity is increased in stable coronary artery disease. Circulation 92:1-343, 1995 (abstr)
96. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA: Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 12:1475, 1992
97. Langford EJ, Brown AS, Wainwright RJ, de Beider AJ, Thomas MR, Smith RE, Radomski MW, Martin JF, Moncada S: Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet 344:1458, 1994
98. Tschoepe D, Schulthei HP, Kolarov P, Schwippert B, Dannehl K, Nieuwenhuis HK, Kehrel B, Strauer B, Cries FA: Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 88:37, 1993
99. Fijnheer R, Modderman PW, Veldman H, Ouwehand WH, Nieuwenhuis HK, Roos D, de Korte D: Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion 30:20, 1990
100. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS: Progressive platelet activation with storage: Evidence for shortened survival of activated platelets after transfusion. Transfusion 31:409, 1991
101. Divers SG, Kannan K, Stewart RM, Betzing KW, Dempsey D, Fukuda M, Chervenak R, Holcombe RF: Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates. Transfusion 35:292, 1995
102. Triulzi DJ, Kickler TS, Braine HG: Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 32:529, 1992
103. Ault KA, Mitchell J, Hillman RS: Appearance of P-selectin (CD62) during labeling is responsible for the majority of the variability in recovery of In111 labeled platelets. Blood 80:496a, 1992 (abstr, suppl 1)
104. Janes SL, Goodall AH: Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in preeclampsia and pregnancy. Clin Sci 86:731, 1994
105. Devine DV, Andestad G, Nugent D, Carter CJ: Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease. Arterioscler Thromb 13:857, 1993
106. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD: Decreased platelet inhibition by nitric oxide in brothers with a history of cerebral arterial thrombosis. J Clin Invest 97:979, 1996
107. Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA: Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17:433, 1991
108. Michelson AD, Rajasekhar D, Bednarek FJ, Barnard MR: Platelet activation in very low birth weight neonates. Thromb Haemost 73:1292, 1995 (abstr)
109. Setzer ES, Webb IB, Wassenaar JW, Reeder JD, Mehta PS, Eitzman DV: Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant. J Pediatr 100:599, 1982
110. Coller BS, Anderson K, Weisman HF: New antiplatelet agents: Platelet GPIIb/IIIa antagonists. Thromb Haemost 74:302, 1995
111. The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956, 1994
112. Konstantopoulos K, Kamat SG, Schafer AI, Banez EI, Jordan R, Kleiman NS, Heliums JD: Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation 91:1427, 1995
113. Larsson A, Lindahl TL: Inhibition of fibrinogen binding to platelets by MK-852 and RO 44-9883, two low molecular weight GPIIb/IIIa antagonists. Thromb Haemost 73:997, 1995 (abstr)
114. Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein IIb/ IIIa receptors in cardiovascular medicine. N Engl J Med 332:1553, 1995
115. Michelson AD: Flow cytometric analysis of platelet surface glycoproteins: Phenotypically distinct subpopulations of platelets in children with chronic myeloid leukemia. J Lab Clin Med 110:346, 1987
116. Jennings LK, Ashmun RA, Wang WC, Dockter ME: Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Blood 68:173, 1986
117. Lages B, Shattil SJ, Bainton DF, Weiss HJ: Decreased content and surface expression of alpha-granule membrane protein GMP-140 in one of two types of platelet alpha delta storage pool deficiency. J Clin Invest 87:919, 1991
118. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 264:17049, 1989
119. Nieuwenhuis HK, Akkerman JW, Sixma JJ: Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: Studies on one hundred six patients. Blood 70:620, 1987
120. Lorez HP, Richards JG, Da Prada M, Picotti GB, Pareti FI, Capitanio A, Mannucci PM: Storage pool disease: Comparative fluorescence microscopical, cytochemical and biochemical studies on amine-storing organelles of human blood platelets. Br J Haematol 43:297, 1979
121. Gordon N, Thorn J, Cole C, Baker R: Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol 89:117, 1995
122. Wall JE, Buijs-Wilts M, Arnold JT, Wang W, White MM, Jennings LK, Jackson CW: A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol 89:380, 1995
123. Gawaz MP, Bogner C, Gurland HJ: Flow-cytometric analysis of mepacrine-labelled platelets in patients with end-stage renal failure. Haemostasis 23:284, 1993
124. Kienast J, Schmitz G: Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75:116, 1990
125. Bonan JL, Rinder HM, Smith BR: Determination of the percentage of thiazole orange (TO)-positive, reticulated platelets using autologous erythrocyte TO fluorescence as an internal standard. Cytometry 14:690, 1993
126. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS: The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 98:637, 1992
127. Romp KG, Peters WP, Hoffman M: Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: An aid in assessing marrow recovery. Am J Hematol 46:319, 1994
128. Jy W, Horstman LL, Arce M, Ahn YS: Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119:334, 1992
129. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ: Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192, 1993
130. Rajasekhar D, Barnard MR, Bednarek FJ, Benoit SE, Michelson AD: Procoagulant activity of platelet-derived microparticles in whole blood: Differences between neonates and adults. Blood 82:163a, 1993 (abstr, suppl 1)
131. Nomura S, Komiyama Y, Miyake T, Miyazaki Y, Kido H, Suzuki M, Kagawa H, Yanabu M, Takahashi H, Fukuhara S: Amyloid beta-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 72:519, 1994
132. Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691, 1994
133. Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, Valeri CR: Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 71:633, 1994
134. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR: Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78:1730, 1991
135. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR: Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 79:1201, 1992
136. Forsberg B, Jacobsson S, Stockelberg D, Kutti J, Rydberg L, Wadenvik H: The platelet specific alloantigen PlA1 (HPA-1a): A comparison of flow cytometric immunophenotyping and genotyping using polymerase chain reaction and restriction fragment length polymorphism in a Swedish blood donor population. Transfusion 35:241, 1995
137. Marshall LR, Brogden FE, Roper TS, Barr AL: Antenatal platelet antibody testing by flow cytometry - Results of a pilot study. Transfusion 34:961, 1994
138. Holme S, Heaton A, Kunchuba A, Hartman P: Increased levels of platelet associated IgG in patients with thrombocytopenia are not confined to any particular size class of platelets. Br J Haematol 68:431, 1988
139. Rosenfeld CS, Bodensteiner DC: Detection of platelet allo-antibodies by flow cytometry. Characterization and clinical significance. Am J Clin Pathol 85:207, 1986
140. Gates K, MacPherson BR: Retrospective evaluation of flow cytometry as a platelet crossmatching procedure. Cytometry 18:123, 1994
141. Davies TA, Drotts D, Weil GJ, Simons ER: Flow cytometric measurements of cytoplasmic calcium changes in human platelets. Cytometry 9:138, 1988
142. Jennings LK, Dockter ME, Wall CD, Fox CF, Kennedy DM: Calcium mobilization in human platelets using indo-1 and flow cytometry. Blood 74:2674, 1989
143. Cattaneo M, Kinlough-Rathbone RL, Lecchi A, Bevilacqua C, Packham MA, Mustard JF: Fibrinogen-independent aggregation and deaggregation of human platelets: Studies of two afibrinogenemic patients. Blood 70:221, 1993
144. Shattil SJ, Haimovich B, Cunningham M, Lipfert L, Parsons JT, Ginsberg MH, Brugge JS: Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem 269:14738, 1994
145. LaRosa CA, Rohrer MJ, Benoit SE, Barnard MR, Michelson AD: Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIbα and by a cytoskeletal-mediated redistribution of the remainder of the complex. Blood 84:158, 1994